CorMedix CRMD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $38.6M+87.0% | $14.02M— | $108.56M+4,010% | $19.83M+240% | $20.64M+243% | ||
| $10.54M+6,409% | $294.1K+260% | $161.92K+536% | $58.99K+137% | $162K+642% | ||
| $4.58M+30.9% | $3.59M+201% | $4.07M+231% | $2.68M+112% | $3.5M+43.2% | ||
| $12.96M— | —— | -$59.7M— | $521.51K— | $0+100% | ||
| —— | $99.5K— | $99.5K— | $99.5K— | $99.5K— | ||
| -$16.45M-655% | $12.4M-64.0% | $87.27M+408% | -$11.71M— | $2.97M— | ||
| $1.02M+1,006% | $800.12K-15.8% | $642.98K-75.6% | $2.15M+26.9% | -$112K-152% | ||
| $4.94M+2,221% | —— | $6.5M+425% | $3.88M— | $213K+115% | ||
| -$50.62M-17,436% | $52.28M+249% | $54.73M+484% | -$6.53M-719% | $292K+112% | ||
| $2.26M-0.4% | $1.36M+149% | —— | —— | $2.27M+84.8% | ||
| -$672K-1,361% | $363.23K+145,292,002,500% | —— | —— | -$46K-18,399,999,900% | ||
| $42.38M+115% | $94.46M+1,782% | $30.86M+326% | $29.99M+314% | $19.74M+214% | ||
| $729K+7,190% | $1.72M+16,865% | $505.77K+5,079% | $24.12K-30.7% | $10K-83.7% | ||
| $0-100% | $1.25M-76.4% | $1.25M-25.1% | $28.29M+134% | $9.99M+29.8% | ||
| $3.69M-62.3% | $3.6M-28.0% | $33.79M+322% | $8.1M-56.0% | $9.8M-41.3% | ||
| $2.97M+1,621% | $0— | -$291.32M-4,709% | -$20.21M-422% | -$195K-102% | ||
| $11.09M— | —— | —— | —— | $0— | ||
| $0-100% | $1.03M-81.4% | —— | —— | $6.76M— | ||
| $1.53M+49.9% | $257.44K+382% | $464.09K— | $247.47K+77.4% | $1.02M+949% | ||
| $522K— | —— | —— | —— | $0— | ||
| $135K— | $138.81K— | $49.19K— | $0— | $0— | ||
| -$12.1M-299% | $0-100% | $150.53M+970% | $83.24M+7,778% | $6.09M+6,374% | ||
| $0— | —— | $276— | $1.06K+1,301% | $0+100% | ||
| $33.25M+29.7% | $96.34M— | —— | $93.02M+1,485% | $25.64M+403% | ||
| $2.82M+28,070% | $321-96.7% | $0-100% | $6.68K+1.9% | $10K+1.7% | ||
| —— | $4.5K— | $4.5K— | $4.5K— | $4.5K— | ||
| —— | $99.5K— | $99.5K— | $99.5K— | $99.5K— | ||
| —— | $1.63M— | $1.63M— | $1.63M— | $1.63M— | ||
| -$4.2M— | -$4.1M— | —— | —— | $0— | ||
| —— | -$25K— | -$25K— | -$25K— | -$25K— | ||
| —— | $21.5K— | $21.5K— | $21.5K— | $21.5K— | ||
| $2.26M-0.4% | $1.36M+149% | —— | —— | $2.27M+84.8% | ||
| -$672K-1,361% | -$63K-83.9% | -$63K-83.9% | -$63K-83.9% | -$46K-34.3% | ||
| $220K— | —— | —— | —— | $0— | ||
| $0-100% | $73.94K-98.6% | $9.61M+476% | $28.29M+134% | $9.99M+29.8% | ||
| $3.69M-62.3% | $3.6M-28.0% | $33.79M+322% | $8.1M-56.0% | $9.8M-41.3% | ||
| $97K— | —— | —— | —— | $0— | ||
| —— | $3.19M+1,015% | $3.19M+1,015% | $3.19M+1,015% | $3.19M+1,015% | ||
| —— | —— | 17%— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | 0.1%+6.9% | —— | —— | —— | ||
| —— | $530.5K— | $530.5K— | $530.5K— | $530.5K— | ||
| $3.55M— | -$2.27M— | —— | —— | $0— | ||
| $53K— | —— | —— | —— | $0— | ||
| —— | $12.32M— | $12.32M— | $12.32M— | $12.32M— | ||
| —— | $15.5K+933% | $15.5K+933% | $15.5K+933% | $15.5K+933% | ||
| $41.65M+111% | $92.74M+1,749% | $30.35M+322% | $29.97M+313% | $19.73M+214% | ||
| $41.65M+111% | $92.74M+1,749% | $30.35M+322% | $29.97M+313% | $19.73M+214% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CorMedix generate?
- CorMedix (CRMD) generated $197.7M in operating cash flow over the trailing twelve months.
- What is CorMedix's free cash flow?
- After $3.0M of capital expenditures, CorMedix's free cash flow was $194.7M over the trailing twelve months, up 1528.3% year over year.
- Where does CorMedix's cash flow data come from?
- Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
